APA (7th ed.) Citation

Stock, J., Tönshoff, B., & Höcker, B. (2017). Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations. Pediatric nephrology, 32(1), . https://doi.org/10.1007/s00467-016-3452-z

Chicago Style (17th ed.) Citation

Stock, Johanna, Burkhard Tönshoff, and Britta Höcker. "Prospective Study on the Potential of RAAS Blockade to Halt Renal Disease in Alport Syndrome Patients with Heterozygous Mutations." Pediatric Nephrology 32, no. 1 (2017). https://doi.org/10.1007/s00467-016-3452-z.

MLA (9th ed.) Citation

Stock, Johanna, et al. "Prospective Study on the Potential of RAAS Blockade to Halt Renal Disease in Alport Syndrome Patients with Heterozygous Mutations." Pediatric Nephrology, vol. 32, no. 1, 2017, https://doi.org/10.1007/s00467-016-3452-z.